4//SEC Filing
Parison Amy 4
Accession 0001650664-25-000142
CIK 0001650664other
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 4:20 PM ET
Size
4.9 KB
Accession
0001650664-25-000142
Insider Transaction Report
Form 4
Parison Amy
SVP, Chief Financial Officer
Transactions
- Sale
Common Stock
2025-09-03$2.60/sh−458$1,189→ 16,369 total
Footnotes (1)
- [F1]Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2025. The sale does not represent a discretionary trade by the Reporting Person.
Documents
Issuer
Editas Medicine, Inc.
CIK 0001650664
Entity typeother
Related Parties
1- filerCIK 0002063082
Filing Metadata
- Form type
- 4
- Filed
- Sep 3, 8:00 PM ET
- Accepted
- Sep 4, 4:20 PM ET
- Size
- 4.9 KB